Turn Therapeutics (TTRX) EPS (Basic) (2024 - 2026)

Turn Therapeutics' EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.11 for Q1 2026.

• In Q1 2026, EPS (Basic) fell 402.38% year-over-year to -$0.11; the TTM figure through Mar 2026 stood at -$0.48 (changed N/A YoY), while the FY2025 annual figure was -$0.5, down 136.77% from the prior year.
• EPS (Basic) for Q1 2026 stood at -$0.11, down from -$0.11 in the prior quarter.
• The five-year high for EPS (Basic) was -$0.02 in Q4 2024, with the low at -$0.27 in Q3 2025.
• The 3-year median for EPS (Basic) is -$0.07 (2024), against an average of -$0.09.
• The sharpest annual moves came in 2025 and 2026: EPS (Basic) slumped 603.48% in 2025, then slumped 402.38% in 2026.
• Turn Therapeutics' EPS (Basic) stood at -$0.02 in 2024, then sank by 498.38% to -$0.11 in 2025, then decreased by 1.08% to -$0.11 in 2026.
• Business Quant data shows TTRX's EPS (Basic) at -$0.11 in Q1 2026, -$0.11 in Q4 2025, and -$0.27 in Q3 2025.